Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes.~* At least 30 years old and less than 80 years old.~* Using oral agents without insulin for 30 days prior ot study.~* Willing to start insulin injections using a pen device.~* Keep a patient diary.~Exclusion Criteria:~* Undergoing therapy for cancers.~* History of renal transplant or receiving renal dialysis.~* Have participated in an interventional medical, surgical, or pharmaceutical study (a study in which a medical or surgical treatment was given) within 30 days prior to entry into the study.~* Women who are breastfeeding.~* Have been treated with a drug within the last 30 days that has not received regulatory approval.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).